Discontinued — last reported Q2 '25
Business Segments · Goodwill
U.S. Pharmaceutical — Goodwill
McKesson U.S. Pharmaceutical — Goodwill increased by 30.4% to $5.39B in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 30.7%, from $4.12B to $5.39B. Over 3 years (FY 2022 to FY 2025), U.S. Pharmaceutical — Goodwill shows relatively stable performance with a 1.5% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ2 2025
Rolls up toGoodwill
How to read this metric
A stable or growing balance indicates successful integration of acquisitions, while a decrease may signal impairment.
Detailed definition
This represents the carrying value of goodwill allocated to the U.S. Pharmaceutical segment, resulting from past acquisi...
Peer comparison
Standard balance sheet item for companies that have grown through M&A.
Metric ID:
mck_segment_u_s_pharmaceutical_goodwillHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.97B | $3.95B | $3.94B | $3.92B | $3.89B | $3.86B | $4.05B | $4.05B | $4.05B | $4.04B | $4.04B | $4.12B | $4.12B | $4.12B | $4.12B | $4.13B | $5.39B |
| QoQ Change | — | -0.4% | -0.3% | -0.5% | -0.9% | -0.7% | +4.9% | +0.0% | -0.1% | -0.0% | +0.0% | +2.0% | +0.0% | +0.0% | +0.0% | +0.2% | +30.4% |
| YoY Change | — | — | — | — | -2.1% | -2.4% | +2.7% | +3.2% | +4.1% | +4.7% | -0.2% | +1.8% | +1.9% | +2.0% | +2.0% | +0.2% | +30.7% |
Range$3.86B – $5.39B
CAGR+7.9%
Avg YoY Growth+3.8%
Median YoY Growth+2.0%
Current Streak7 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's u.s. pharmaceutical — goodwill?
- McKesson (MCK) reported u.s. pharmaceutical — goodwill of $5.39B in Q2 2025.
- How has McKesson's u.s. pharmaceutical — goodwill changed year-over-year?
- McKesson's u.s. pharmaceutical — goodwill increased by 30.7% year-over-year, from $4.12B to $5.39B.
- What is the long-term trend for McKesson's u.s. pharmaceutical — goodwill?
- Over 3 years (2022 to 2025), McKesson's u.s. pharmaceutical — goodwill has grown at a 1.5% compound annual growth rate (CAGR), from $15.79B to $16.50B.
- What does u.s. pharmaceutical — goodwill mean?
- The value of intangible assets like brand and market position recorded for the U.S. Pharmaceutical segment.